Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00968565 · ClinicalTrials.gov registry record · Early Phase 1
Study Using Citrate to Replace Heparin in Babies Requiring Extracorporeal Membrane Oxygenation (ECMO)
A Early Phase 1 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 2
- Enrollment target
NCT00968565: Completed Early Phase 1 study, sponsored by Vanderbilt University.
NCT00968565 is a Early Phase 1 study that has completed, run by Vanderbilt University. The registered enrollment target is 2 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00968565, a Early Phase 1 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and efficacy of citrate to provide anticoagulation of an ECMO circuit without patient anticoagulation. The standard method of providing ECMO circuit anticoagulation is the use of heparin which also anticoagulates the patient and increases the risk of patient bleeding.
Interventions
- DRUG sodium citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2010-01 |
| Est. Completion | 2015-06 |
| Phase | Early Phase 1 |
What the finished NCT00968565 record still lists
NCT00968565 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which sodium citrate is the first listed.
NCT00968565 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00968565 about?
NCT00968565 is a clinical study titled "Study Using Citrate to Replace Heparin in Babies Requiring Extracorporeal Membrane Oxygenation (ECMO)". The purpose of this study is to determine the safety and efficacy of citrate to provide anticoagulation of an ECMO circuit without patient anticoagulation. The standard method of providing ECMO circuit anticoagulation is the use of heparin which also anticoagulates the patient and increases the risk...
What is the current status of trial NCT00968565?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 2 participants. The study started on 2010-01. Estimated completion is 2015-06.
What interventions are being tested in trial NCT00968565?
The interventions under investigation include: sodium citrate (DRUG).
Who is sponsoring clinical trial NCT00968565?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00968565's enrollment target sits among peer trials
2 1974th of 2000 higher than 16 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia